Page last updated: 2024-08-21

emetine and Astrocytoma, Grade IV

emetine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bradley, KA; Damoiseaux, R; De Vries, D; Ferrari, D; Huang, J; Kornblum, HI; Masterman-Smith, M; Mottahedeh, J; Nakano, I; Onodera, H; Panosyan, EH; Petrosyan, S; Sabatti, C; Saigusa, K; Saxe, J; Visnyei, K	1

Other Studies

1 other study(ies) available for emetine and Astrocytoma, Grade IV

Article	Year
A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells. Molecular cancer therapeutics, 2011, Volume: 10, Issue:10 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Culture Media, Serum-Free; Emetine; Epidermal Growth Factor; Fibroblast Growth Factors; Gene Expression; Glioblastoma; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Xenograft Model Antitumor Assays	2011

Article

Year

A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.

Molecular cancer therapeutics, 2011, Volume: 10, Issue:10

Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Culture Media, Serum-Free; Emetine; Epidermal Growth Factor; Fibroblast Growth Factors; Gene Expression; Glioblastoma; High-Throughput Screening Assays; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Xenograft Model Antitumor Assays

2011